Project description
In situ oral disinfection with plasma technology
Oral hygiene is important not only for aesthetic reasons but also for overall health as gum disease and subsequent inflammation have been linked to heart and kidney disease. Funded by the European Innovation Council, the AmbiJet project is introducing a proprietary technology that permits in situ disinfection of and around dental implants. The solution is based on plasma technology, has no side effects, and demonstrates superior effectiveness to current treatment options. Furthermore, it reduces the chance of re-infection, sparing further patient suffering.
Objective
Regular dental check-ups and treatments not only ensure a beautiful smile, but good general health: a healthy oral cavity strengthens the immune system and acts as a barrier against various heart-, kidney-, or lungs-related diseases and diabetes. There is currently no effective solution to treat the 16.3 mn infected dental implants (EU, 2019). Freiburger Medizintechnik GmbH developed the solution dentists are looking for: a disruptive technology for highly effective infection control to fight periimplantitis. AmbiJet is the worlds first and only plasma-based technology with the ability to kill bacteria on dental implants in-situ. It disrupts the status-quo of medical technologies by preventing the reinfection of disinfected surfaces and shows maximum effectiveness without side nor adverse effects: pharmacological and chemical substances are no longer required. AmbiJet reduces inflammation, saves dental implants and helps patients live a healthier life.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
- natural sciencesbiological sciencesmicrobiologybacteriology
- medical and health sciencesclinical medicineendocrinologydiabetes
- medical and health sciencesmedical biotechnologyimplants
You need to log in or register to use this function
Keywords
Programme(s)
- HORIZON.3.1 - The European Innovation Council (EIC) Main Programme
Funding Scheme
HORIZON-EIC-ACC-BF - HORIZON EIC Accelerator Blended FinanceCoordinator
79115 Freiburg
Germany
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.